All News

Novo Nordisk announced results of the evoke and evoke+ phase 3 trials on semaglutide’s use in treating Alzheimer disease progression.

Catie Stimmel, PharmD, discusses the pharmacist’s role in ensuring PSOs operate at their intended capabilities.

Key sessions from the National Community Pharmacists Association 2025 Annual Convention & Expo highlight pharmacy benefit manager reform, pneumococcal vaccines, and billable services.

Morgan McSweeney, PhD, discusses how social media highlights the most emotionally charged voices, often those offering anecdotes or outrage over careful analysis.

Tardive dyskinesia presents significant challenges for patients, but new FDA-approved treatments offer hope for improved management and quality of life.

Catie Stimmel, PharmD, explores the confidentiality and non-punitive processes that are crucial in driving value toward patient safety organizations.

Catie Stimmel, PharmD, discusses what PSOs are and how they are protecting patients all across the US health care system.

High-profile figures often share misleading health information, highlighting the need for trusted and evidence-based content in social media discussions.

Experts at the Milken Institute address better ways of adopting pharmacy services within the greater health care ecosystem.

After nearly 20 years of pneumococcal conjugate vaccine use in the Portuguese vaccine schedule, researchers explore serotype distribution in bacteria causing adult invasive pneumococcal disease (IPD).

The CDC argues the statement “vaccines do not cause autism” is not evidence based because studies have not ruled out the possibility that vaccines do not contribute to the development of autism.

In a conversation with NCPDP’s Rick Sage, he explored the lasting effects on pharmacy stemming from the record-breaking government shutdown.

Regeneron Pharmaceuticals’ newest drug will be the first and only approved flexible treatment option for retinal vein occlusion.

The FDA approves denosumab biosimilars Osvyrti and Jubereq, expanding treatment options for osteoporosis and bone-related conditions.

A study reveals declining support for COVID-19 measures over time, highlighting the critical role of pharmacists in providing essential health education.

Patients tend to trust their physician to deprescribe more than their community pharmacist.

In this episode, Natalie DiPietro Mager, PharmD, PhD, MPH, meets with pharmacists from Ohio State University to discuss smoking trends among women.

Rick Sage, executive vice president of innovation and standards with the NCPDP, discusses the nuances of billing under either Medicare Part B or D.

Pharmacists enhance diabetes care through text messaging interventions, improving medication adherence and glycemic control in patients with complex treatment plans.

Researchers explore the no-cost uptake of 2 separate emergency contraception methods.

Study authors explore online purchasing habits for prescription-only and OTC medications.

A study reveals first-trimester SARS-CoV-2 infection increases neonatal risks and highlights disparities in testing among pregnant women across demographics.

Researchers explore OTC medication misuse among adults over 65 in Saudi Arabia.

A recent review highlights cardiovascular risks linked to albuterol use in asthma treatment, urging safer alternatives and enhanced patient monitoring strategies.

Researchers address the potential association of access to maternal care with the increased risk of infant mortality.

US adults show an increase in recreational activity post-COVID-19, but lingering cardiovascular risks from infection highlight the need for ongoing health vigilance.

The study highlights disparities in COVID-19 vaccine access, revealing urban pharmacies excel while rural areas face significant challenges, urging policy changes for equity.

With disease cases increasing substantially between 2012 and 2024, higher-valent vaccines are necessary to protect against nonvaccine serotypes and invasive pneumococcal disease.